Literature DB >> 11203324

Outer surface protein A and arthritis in hamsters.

D L Parenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11203324      PMCID： PMC97844          DOI： 10.1128/IAI.68.12.7212-7213.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  10 in total

1.  Occurrence of severe destructive lyme arthritis in hamsters vaccinated with outer surface protein A and challenged with Borrelia burgdorferi.

Authors:  C L Croke; E L Munson; S D Lovrich; J A Christopherson; M C Remington; D M England; S M Callister; R F Schell
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.

Authors:  L H Sigal; J M Zahradnik; P Lavin; S J Patella; G Bryant; R Haselby; E Hilton; M Kunkel; D Adler-Klein; T Doherty; J Evans; P J Molloy; A L Seidner; J R Sabetta; H J Simon; M S Klempner; J Mays; D Marks; S E Malawista
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

3.  Macrophages interact with enriched populations of distinct T lymphocyte subsets for the induction of severe destructive Lyme arthritis.

Authors:  B K DuChateau; E L Munson; D M England; S D Lovrich; S M Callister; J R Jensen; R F Schell
Journal:  J Leukoc Biol       Date:  1999-02       Impact factor: 4.962

4.  Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi.

Authors:  R A Kalish; J M Leong; A C Steere
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

5.  Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.

Authors:  L C Lim; D M England; N J Glowacki; B K DuChateau; R F Schell
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

6.  Characterization of the protective borreliacidal antibody response in humans and hamsters after vaccination with a Borrelia burgdorferi outer surface protein A vaccine.

Authors:  M L Padilla; S M Callister; R F Schell; G L Bryant; D A Jobe; S D Lovrich; B K DuChateau; J R Jensen
Journal:  J Infect Dis       Date:  1996-10       Impact factor: 5.226

7.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.

Authors:  D M Gross; T Forsthuber; M Tary-Lehmann; C Etling; K Ito; Z A Nagy; J A Field; A C Steere; B T Huber
Journal:  Science       Date:  1998-07-31       Impact factor: 47.728

8.  Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.

Authors:  A C Steere; V K Sikand; F Meurice; D L Parenti; E Fikrig; R T Schoen; J Nowakowski; C H Schmid; S Laukamp; C Buscarino; D S Krause
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

9.  Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.

Authors:  L C Lim; D M England; B K DuChateau; N J Glowacki; J R Creson; S D Lovrich; S M Callister; D A Jobe; R F Schell
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

10.  The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis.

Authors:  E Akin; G L McHugh; R A Flavell; E Fikrig; A C Steere
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.